Your Ad Here
0 Plus Temp Mail Service 777 Store Service

2011年1月19日 星期三

Obstructive Sleep Apnea prevalence in UAE: Philips "do you Snore" Online research

Translate Request has too much data
Parameter name: request
Translate Request has too much data
Parameter name: request

UAE Philips conducted an online Sleep Apnea Awareness campaign titled Do You Snore, to help build public consciousness about Obstructive Sleep Apnea (OSA) in the UAE. Email invitations were sent out to fill out a short and straight forward survey to more than 200,000 recipients based in the country, targeting a sample group of the age 25 and above.

A high number of respondents showed positive results and are very likely to be suffering fromObstructive Sleep Apnea (?OSA). The potential patients were advised to print their report and seek further medical advice and diagnostic tests for sleep apnea.

Obstructive Sleep Apnea is one of the most common sleep disorders worldwide. It is a condition that causes a persons breathing to stop repeatedly during the night, causing disruption in their sleep as they struggle to breathe. As a result, they never get the deep, restorative sleep that is needed. Obstructive sleep apnea (OSA) can not only negatively impact a persons overall quality of life and productivity, but it can also potentially lead to serious health issues like increasing the risk of type 2 diabetes, high blood pressure, abnormal heart rhythm, strokes and other conditions.

Individuals with moderate to severe OSA often have a number of symptoms including loud, disruptive snoring, gasping for air or choking during sleep, and excessive daytime sleepiness. OSA can easily be diagnosed by physicians upon assessing a patients complaints and symptoms. If sleep apnea is suspected, a patient will be referred for a diagnostic sleep study known as a polysomnogram (PSG), to confirm the type and severity of the sleep apnea, as well as the appropriate treatment.

Philips will be hosting the 2nd Gulf? Sleep Apnea Meeting on the 16th of December, inviting sleep medicine clinicians from around the Gulf and Middle East to discuss the surveys outcome and give deeper insights on topics related to sleep apnea such as Obstructive Sleep Apnea (OSA) and Cardiovascular Diseases, Sleep and Aging, as well as showcasing the latest solutions in OSA Therapy Systems. affects approximately 4% of the adult population worldwide. A large proportion of cases remain undiagnosed, said Diederik Zeven, Senior Director and General Manager of Philips Healthcare Middle East. Most people fail to seek medical diagnosis for this most common form of sleep disorder breathing. Treating OSA can limit the risk of developing the life-threatening conditions mentioned earlier and improve quality of life, he adds.

Obstructive Sleep Apnea

Related Posts with Thumbnails

Tagged with:

Filed under: Cardiovascular DiseaseDaytime SleepinessDepressionFatigueHeadacheHeart AttackHeart DiseaseHeart ProblemsHigh Blood PressureObstructive Sleep ApneaOther DisordersPolysomnographyPress ReleaseRestless Leg SyndromeSleepSleep ApneaSleep Apnea AwarenessSleep Apnea DiagnosisSleep Apnea EffectsSleep Apnea EventsSleep Apnea NewsSleep Apnea SupportSleep Apnea SymptomsSleep Apnea TestSleep Apnea TreatmentSleep DeprivationSleep Disordered BreathingSleep DisordersSleep ProblemsSleep StudySleepwalkingSnoringSnoring SolutionSnoring TreatmentStressStrokeType 2 Diabeteshypersomnia

Like this post? Subscribe to my RSS feed and get loads more!


View the original article here

沒有留言:

張貼留言